Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.05 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
16:00 - 16:10 | Presenter: Corey Jay Langer | Author(s): Shirish Gadgeel, Hossein Borghaei, Amita Patnaik, Steven F. Powell, Ryan D Gentzler, James Chih-Hsin Yang, Matthew A. Gubens, Lecia Sequist, Mark Awad, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-17 - Phase I/II Study of Nivolumab and Vorolanib in Patients with Refractory Thoracic Tumors
09:45 - 09:45 | Presenter: Leora Horn | Author(s): Jennifer G. Whisenant, Kathryn E Beckermann, Hossein Borghaei, Taofeek Owonikoko, Jyoti D Patel, Lynn D. Berry, Yu Shyr, Kim Harrow, Chris Liang, Allison Holzhausen, Giovanni Selvaggi, Heather A Wakelee
- Abstract
Loading...
-
+
IS12 - Symposium by Medscape: Expanding the Therapeutic Landscape Of Advanced NSCLC Targeting HER2 (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/09/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-64 - 222 NSCLC’s Classified by PAM50: Luminal A NSCLC Is a Distinct Subtype with Low TMB and Immune Suppressive TME
10:15 - 10:15 | Presenter: Hossein Borghaei | Author(s): Sandeep Reddy, Christopher Szeto
- Abstract
Loading...
-
+
ES24 - Diagnosis and Management of Side Effects of Immunotherapy
- 11:30 - 13:00
- 9/10/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-oncology
- Moderators:Daniel SW Tan, Joachim G.J.V. Aerts
-
+
ES24.01 - Recognizing Toxicities in an Early Phase in PDL1 Treatment
11:30 - 11:50 | Presenter: Hossein Borghaei
- Abstract
No abstract available for this presentation
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading...
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.01 - Pembrolizumab Plus Chemotherapy for Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407
14:30 - 14:37 | Presenter: Hossein Borghaei | Author(s): Corey Jay Langer, Luis Paz-Ares, Delvys Rodriguez Abreu, Balazs Halmos, Vassiliki A Papadimitrakopoulou, Marina Chiara Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, M. Catherine Pietanza, Bilal Piperdi, Shirish Gadgeel
- Abstract
Loading...
-
+
PC05 - Immune Chekpoint Inhibitors in Real World - How Do We Treat NSCLC ''Special Populations''
- 14:30 - 16:00
- 9/10/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Advanced NSCLC
- Moderators:Oscar Juan, Fernando José Barata
-
+
PC05.04 - ICIs for Elderly Patients with Advanced NSCLC
15:15 - 15:30 | Presenter: Hossein Borghaei
- Abstract
Loading...
